The Cav1.1 p.T1009K variant is a novel pathogenic variant for malignant hyperthermia

Kaura, V. orcid.org/0000-0002-8984-9662, Liu, X., Diggle, C. orcid.org/0000-0001-6861-359X et al. (2 more authors) (2022) The Cav1.1 p.T1009K variant is a novel pathogenic variant for malignant hyperthermia. In: British Journal of Anaesthesia. Anaesthetic Research Society / BJA Research Forum as part of the RCoA Anaesthesia Research 2021 Joint Virtual Meeting, 10-11 Nov 2021 Elsevier , e60.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Dates:
  • Published: February 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Molecular Medicine
Funding Information:
Funder
Grant number
National Institute of Health - NIH (PHS)
7R01AR068897-02
Depositing User: Symplectic Publications
Date Deposited: 01 Jul 2024 14:22
Last Modified: 01 Jul 2024 14:22
Published Version: http://dx.doi.org/10.1016/j.bja.2021.11.002
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.bja.2021.11.002
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)